Federal Advocacy Update that you need to become involved with: There are three resolutions that NPCC is currently educating legislators about: H.Res 672 is sponsored by Doris Matui's office (CA-5) and it supports the goals and ideals of National Prostate Cancer Awareness Month in September. This resolution recognizes the main issues surrounding the lack of [...]
Are you taking Fosamax to help combat osteoporosis? Many of us take Fosamax as one of the most common side effects of a hormone blockade (ADT) is loss of bone density. ADT causes osteoporosis, or a decrease in bone density, which diminishes bone strength. A decrease in your bone density increases your chance to suffer [...]
Five years ago today my boy barged into our lives and decided to stay. I am thrilled and blessed by his decision. I never really saw myself as a parent, but he was able to change that swiftly and decisively. At first glance, covered in goop and slime, I knew he was mine - the [...]
Taxotere (chemotherapy for prostate cancer) is administered intravenously usually in an cancer center or a hospital setting. Often the areas which are designated for chemo administration are referred to as infusion centers. Taxotere is administered with either on a higher dosage schedule of once every three weeks (q3wk) or a lower dosage schedule of once [...]
The current standard of care in the treatment of prostate cancer is to use chemotherapy (Taxotere) only in late stage hormone refractory prostate cancer. Most other cancers use chemotherapy agents at a much earlier stage then used for prostate cancer. Prostate cancer cells divide at a rate that is not much faster than normal cell [...]